In ovarian cancer cells, the inhibition of BET decreases PD-L1 expression, tumor-associated dendritic cells and macrophages but increases the activity of antitumor cytotoxic T cells, limiting tumor progression [82]. This evidence concerns the gene CD274 and ovarian cancer.